Real-world experience of the 6 weekly schedule (q6w) of pembrolizumab in patients (pts) with metastatic non-small cell lung cancer (mNSCLC)

被引:0
|
作者
Tariq, Noor-Ul-Ain [1 ]
Anderson, Christian [2 ]
Gartside, Eleanor [1 ]
Wong, Helen [1 ]
Dobson, Lisa [1 ]
Anthonypillai, Marry [1 ]
Griffiths, Richard [1 ]
Pope, Anthony [1 ]
机构
[1] Clatterbridge Canc Ctr, Liverpool, Merseyside, England
[2] Univ Liverpool, Clatterbridge, England
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
80
引用
收藏
页码:S38 / S38
页数:1
相关论文
共 50 条
  • [31] Real-World Patient-Reported Outcome Assessment of Patients with Metastatic Non-Small Cell Lung Cancer
    Williams, L.
    Dibaj, S.
    Chandwani, S.
    Vaghani, V.
    Shi, Q.
    Hirschmann, M.
    Landry, L. L.
    Roarty, E.
    Zhang, J.
    Rinsurnogkawong, W.
    Lewis, J.
    Burke, T.
    Cleeland, C.
    Lee, J.
    Roth, J. A.
    Swisher, S.
    Heymach, J.
    Simon, G.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S907 - S908
  • [32] Determining Lines of Therapy in Patients with Metastatic Non-Small Cell Lung Cancer Using Real-World Data
    Grady, C. B.
    Sun, L.
    Reuss, J. E.
    Cass, A.
    Liu, G.
    Patel, D.
    Liu, S.
    Montenegro, G. B.
    Patil, T.
    Nieva, J.
    Herrmann, A.
    Marrone, K.
    Lam, V.
    Schwartzman, W.
    Villaruz, L.
    Miller, K. L.
    Camidge, D. R.
    Aggarwal, C.
    Hwang, W. -T.
    Marmarelis, M. E.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S408 - S409
  • [33] Real-world biomarker testing trends in metastatic non-small cell lung cancer (NSCLC).
    Clinton, Natasha
    Patel, Manish R.
    Ayars, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18728 - E18728
  • [34] Real-world treatment patterns for metastatic non-small cell lung cancer at IRST Italy
    Altini, M.
    Massa, I.
    Balzi, W.
    Gentili, N.
    Foca, F.
    Danesi, V.
    Manunta, S.
    Burgio, M. A.
    Cravero, P.
    Ejzykowicz, F.
    Chandwani, S.
    Delmonte, A.
    ANNALS OF ONCOLOGY, 2019, 30
  • [35] Real-world KRAS testing and treatment utilization among patients with metastatic non-small cell lung cancer
    Blanc, Simon
    Vasudevan, Anupama
    Gart, Mike
    Sura, Teena
    Shrivastava, Aryamaan
    Varughese, Prateesh
    Scott, Jeffrey A.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [36] A six-weekly (Q6W) dosing schedule for pembrolizumab in patients with cancer based on evaluation using modelling and simulation (vol 131, pg 68, 2020)
    Lala, Mallika
    Li, Tommy Ruosi
    de Alwis, Dinesh P.
    Sinha, Vikram
    Mayawala, Kapil
    Li, Mengyao
    Yamamoto, Noboru
    Siu, Lillian L.
    Chartash, Elliot
    Aboshady, Hesham
    Jain, Lokesh
    EUROPEAN JOURNAL OF CANCER, 2021, 144 : 400 - 400
  • [37] Outcomes in patients with metastatic non-small cell lung cancer (mNSCLC) with brain metastases treated with pembrolizumab-based therapy.
    Sun, Lova
    Davis, Christiana
    Marmarelis, Melina Elpi
    Jeffries, Seth
    Sulyok, Lydia Frenzel
    Hwang, Wei-Ting
    Singh, Aditi Puri
    Berman, Abigail T.
    Feigenberg, Steven J.
    Levin, William C.
    Bauml, Joshua
    Ciunci, Christine Agnes
    Cohen, Roger B.
    Langer, Corey J.
    Aggarwal, Charu
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [38] REAL-WORLD UTILIZATION OF BRIGATINIB IN PATIENTS WITH NON-SMALL CELL LUNG CANCER (NSCLC)
    Lin, H. M.
    Pan, X.
    Hou, P.
    Huang, H.
    Baumann, P.
    Jahanzeb, M.
    VALUE IN HEALTH, 2019, 22 : S115 - S115
  • [39] Real-World Experience With Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer at Frankfurt University Hospital
    Shaid, S.
    Stratmann, J.
    Wolf, A.
    Niklas, N.
    Calleja, A.
    Munro, R.
    Waldenberger, D.
    Carroll, R.
    Daumont, M.
    Penrod, J.
    Lacoin, L.
    Rohde, G.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1003 - S1004
  • [40] Surviving metastatic non-small cell lung cancer (mNSCLC): The lived experience and supportive care needs of patients (pts) receiving immunotherapy (IT) or targeted therapy (TT).
    Lai-Kwon, Julia Elizabeth
    Heynemann, Sarah
    Flore, Jacinthe
    Duffy, Mary
    Kokanovic, Renata
    Jefford, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)